Nonacus will supply Cardiff and Vale's FH genetic testing panel
- Cardiff and Vale University Health Board
- Wales
- Direct award
- 15 April 2027 to 14 April 2029
Cardiff and Vale University Health Board is buying a next generation sequencing panel from Nonacus Ltd for familial hypercholesterolaemia (FH) testing.
The panel will be used in the All Wales Genomics Laboratory for the All Wales Familial Hypercholesterolaemia service. The service handles about 600 tests a year, covering both first and cascade testing. Nonacus will also supply reagents, training and technical support.
The health board awarded the £203,154 contract directly in July 2026. It says Nonacus is the only supplier able to provide the proprietary panel, which is already validated in the laboratory's diagnostic pathway. The two-year contract will start in April 2027.
Contract ends April 2029
- What
- Genomic sequencing platforms and consumables
- Supplier
- Nonacus Ltd
- Value
- £203,154
- How it was bought
- Direct award
- Dates and next
- Apr 2027 to Apr 2029